This study aimed to develop a protocol for obtaining and enriching populations of antitumor cytotoxic T cells specific for tumor-associated protein HER2 and to assess their cytotoxic activity against HER2-expressing MCF-7 tumor cells. This evidence concerns the gene ERBB2 and neoplasm.